Ozempic baj de precio en el pas tras la llegada de su competidor nacional El laboratorio dans Novo Nordisk baj casi un 50% el precio de su medicamento estrella, Ozempic , famoso por su tratamiento contra la diabetes y la obesidad, tras la salida al mercado de su alternativa de industria nacional, Dutide , de la empresa Elea
Semaglutide has become one of the most studied weight loss medications, with clinical trials showing average weight reductions of 10-15% over 68 weeks at therapeutic doses
Fig.2 Pleiotropic effects of GLP1-RA leading to improvement MASLD/MASH [2] GLP-1RA in MASH Treatment: Clinical Progress Several GLP-1RAs and related agents are currently in various phases of clinical development for MASH treatment [4]
Reduction in Obesity-Related Conditions : Weight loss with semaglutide can reduce the severity of other obesity-related conditions, such as sleep apnea and fatty liver disease
The early meta-analysis indicated that gonadotropin-releasing hormone agonists can well protect the ovarian function of breast cancer patients during chemotherapy
